Evidence map›Paper›PMID 25502948›Full record

Trial reportJournal of Parkinson's disease2015

Dopaminergic modulation of arm swing during gait among Parkinson's disease patients.

Nicholas W Sterling, Joseph P Cusumano, Noam Shaham, Stephen J Piazza, Guodong Liu, Lan Kong, Guangwei Du, Mechelle M Lewis, Xuemei Huang

Registry-linked trialOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in Journal of Parkinson's disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06816810 (TALLman Family Energizes Research To Help Alleviate Neuroinflammation in Parkinson's Disease - "TALLER THAN PD." A Phase 2 Futility Study to Evaluate the Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Early Treated Parkinson's Disease), which is not on this map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06816810 phase2not yet recruitingnot on this mapstarted 2025, after this paper: background citation

TALLman Family Energizes Research To Help Alleviate Neuroinflammation in Parkinson's Disease - "TALLER THAN PD." A Phase 2 Futility Study to Evaluate the Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Early Treated Parkinson's Disease

TypeinterventionalSponsorOttawa Hospital Research InstituteRan2025 to 2027Enrolled40ConditionsParkinson&Amp, #39, s DiseaseArmsHydroxychloroquine (HCQ)
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Predicting Ambulatory Capacity in Parkinson's Disease to Analyze Progression, Biomarkers, and Trial Design.Movement disorders : official journal of the Movement Disorder Society · 2023
    Observational
  13. A novel clinical sign to assess the risk of Parkinson's disease in patients with isolated asymmetric arm swing.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Nicholas W SterlingDepartment of Neurology, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA Department of Public Health Sciences, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA.
Joseph P CusumanoDepartment of Engineering Science and Mechanics, The Pennsylvania State University, University Park, PA, USA.
Noam ShahamDepartment of Engineering Science and Mechanics, The Pennsylvania State University, University Park, PA, USA.
Stephen J PiazzaDepartment of Kinesiology, The Pennsylvania State University, University Park, PA, USA.
Guodong LiuDepartment of Public Health Sciences, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA.
Lan KongDepartment of Public Health Sciences, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA.
Guangwei DuDepartment of Neurology, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA.
Mechelle M LewisDepartment of Neurology, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA Department of Pharmacology, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA.
Xuemei HuangDepartment of Neurology, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA Department of Kinesiology, The Pennsylvania State University, University Park, PA, USA Department of Pharmacology, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA Department of Radiology, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA Department of Neurosurgery, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA.
Pennsylvania State University · USPenn State Milton S. Hershey Medical Center · US

Funding

Penn State Clinical and Translational Science InstituteUL1TR000127 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI SINOWAY, LAWRENCE I · 2012 to 2015
$17.1M
Multimodal MRI Markers of Nigrostriatal Pathology in Parkinson's DiseaseU01NS082151 · NINDS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI HUANG, XUEMEI · 2012 to 2016
$4.2M
Structural MRI marker(s) of Parkinson's Disease's ProgressionR01NS060722 · NINDS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI HUANG, XUEMEI · 2009 to 2013
$2.9M
GCRC RELOCATION AND EXPANSION PROJECTC06RR016499 · NCRR · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KIRCH, DARRELL G · 2001 to 2001
$707k
Penn State Clinical and Translational Science InstituteTL1TR000125 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI SINOWAY, LAWRENCE I · 2012 to 2015
$550k
NCATS NIH HHS TL1 TR000125NCATS NIH HHS UL1 TR000127NCRR NIH HHS C06 RR016499NINDS NIH HHS NS060722NINDS NIH HHS NS082151NINDS NIH HHS R01 NS060722NINDS NIH HHS U01 NS082151
6 · The paper itself

Abstract

backgroundReduced arm swing amplitude, symmetry, and coordination during gait have been reported in Parkinson's disease (PD), but the relationship between dopaminergic depletion and these upper limb gait changes remains unclear.

objectiveWe aimed to investigate the effects of dopaminergic drugs on arm swing velocity, symmetry, and coordination in PD.

methodsForearm angular velocity was recorded in 16 PD and 17 control subjects (Controls) during free walking trials. Angular velocity amplitude of each arm, arm swing asymmetry, and maximum cross-correlation were compared between control and PD groups, and between OFF- and ON-medication states among PD subjects.

resultsCompared to Controls, PD subjects in the OFF-medication state exhibited lower angular velocity amplitude of the slower- (p = 0.0018), but not faster- (p = 0.2801) swinging arm. In addition, PD subjects demonstrated increased arm swing asymmetry (p = 0.0046) and lower maximum cross-correlation (p = 0.0026). Following dopaminergic treatment, angular velocity amplitude increased in the slower- (p = 0.0182), but not faster- (p = 0.2312) swinging arm among PD subjects. Furthermore, arm swing asymmetry decreased (p = 0.0386), whereas maximum cross-correlation showed no change (p = 0.7436). Pre-drug angular velocity amplitude of the slower-swinging arm was correlated inversely with the change in arm swing asymmetry (R = -0.73824, p = 0.0011).

conclusionsThis study provides quantitative evidence that reduced arm swing and symmetry in PD can be modulated by dopaminergic replacement. The lack of modulations of bilateral arm coordination suggests that additional neurotransmitters may also be involved in arm swing changes in PD. Further studies are warranted to investigate the longitudinal trajectory of arm swing dynamics throughout PD progression.

Indexed as

AgedArmDopamine AgentsFemaleGait Disorders, NeurologicHumansMaleMiddle AgedMovementParkinson DiseasePsychomotor PerformanceWalkingDopamine AgentsArm swingasymmetrydopaminegaitlocomotionParkinson's disease

Identifiers

PMID25502948
PMCPMC4609542
OpenAlexW1525396078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.